
Catalent inks $133M deal to buy Juniper Pharmaceuticals, adding UK development services
US-based Catalent has agreed to acquire Juniper Pharmaceuticals in a deal valued at around $133m.As per terms of the deal, Juniper will purchase all outstanding shares of Juniper by paying $11.50 per share in cash.Juniper’s […]